Drug Trial Radar · NCT06010342
A Study to Evaluate the Efficacy and Safety of TL118 in Solid Tumors Patients
Last checked: Nov 19, 2026Latest source record: Oct 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
60
Planned (sponsor's estimate)
Start
Mar 16, 2023
Primary completion
Dec 2027
Study completion Dec 2028
Sponsor
- Lead sponsor
- Teligene USIndustry
- Sponsor type
- Industry
- First posted
- Aug 24, 2023
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The main objective of the study will be to evaluate the efficacy of TL118 in participants with solid tumors harboring NTRK gene fusions
Conditions
- Solid Tumor
Interventions
TL118 CapsuleDrug
Oral administration
Primary outcomes
What the sponsor says the trial is designed to measure.
- Objective Response Rate (ORR)Time frame: Pre-dose up to approximately 24 months post-dose
Locations
20 sites in 2 countries. Site status is shown where the registry gives one.
Adventist Health Glendale
Glendale, California · Recruiting
Texas Oncology Dallas
Dallas, Texas · Recruiting
The University of Texas MD Anderson Cancer Center
Houston, Texas · Recruiting
Texas Oncology Lewisville Castle Hills
Lewisville, Texas · Recruiting
Beijing Cancer Hospital
Beijing, Beijing Municipality, China · Recruiting
Peking University School and Hospital of Stomatology
Beijing, Beijing Municipality, China · Recruiting
Chongqing University Cancer Hospital
Chongqing, Chongqing Municipality, China · Recruiting
Fujian Cancer Hospital
Fuzhou, Fujian, China · Recruiting
Affiliated Cancer Hospital and Institute of Guangzhou Medical University
Guangzhou, Guangdong, China · Recruiting
Harbin medical university cancer hospital
Harbin, Heilongjiang, China · Recruiting
The First Affiliated Hospital of Zhengzhou University
Zhengzhou, Henan, China · Recruiting
Union Hospital Tongji Medical College Huazhong University of Science and Technology
Wuhan, Hubei, China · Recruiting
Hunan Cancer Hospital
Changsha, Hunan, China · Recruiting
Jiangxi Cancer Hospital
Nanchang, Jiangxi, China · Recruiting
Shanxi Cancer Hospital
Xi'an, Shaanxi, China · Recruiting
Jinan Central Hospital
Jinan, Shandong, China · Recruiting
Shanghai East Hospital
Shanghai, Shanghai Municipality, China · Recruiting
West China Hospital of Sichuan University
Chengdu, Sichuan, China · Recruiting
Affiliated Cancer Hospital of Xinjiang Medical University
Ürümqi, Xinjiang, China · Recruiting
Zhejiang Cancer Hospital
Hangzhou, Zhejiang, China · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.